<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01417208</url>
  </required_header>
  <id_info>
    <org_study_id>011711</org_study_id>
    <nct_id>NCT01417208</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds</brief_title>
  <official_title>Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KCI USA, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a novel topical negative pressure (TNP) wound&#xD;
      therapy device called the SNaP速 (Smart Negative Pressure) Wound Care System for the treatment&#xD;
      of lower extremity diabetic, venous and mixed aetiology leg wounds.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study was terminated by Spiraur (original sponsor). Efforts were made to contact the&#xD;
    PI/study team members, but were unsuccessful.&#xD;
  </why_stopped>
  <start_date type="Actual">June 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Closure</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Lower Extremity Diabetic Leg Wounds</condition>
  <condition>Lower Extremity Venous Leg Wounds</condition>
  <condition>Lower Extremity Mixed Aetiology Leg Wounds</condition>
  <arm_group>
    <arm_group_label>SNaP速 Wound Care System</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SNaP速 Wound Care System</intervention_name>
    <description>Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.</description>
    <arm_group_label>SNaP速 Wound Care System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diabetic foot ulceration, venous or mixed aetiology lower limb ulceration who&#xD;
        are receiving out-patient treatment from the Section of Wound Healing, Cardiff University,&#xD;
        Wales.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has diabetic foot ulceration, venous ulcer, or mixed aetiology ulcer with a&#xD;
             surface area &lt;100 cm2 and &lt;10 cm in widest diameter on lower extremity, but larger&#xD;
             than 1 cm2 (venous and mixed aetiology ulcers will be defined by clinical exam of&#xD;
             treating physician. Diabetic foot ulcers will be defined by clinical exam of the&#xD;
             treating physician and as lower extremity ulcers in patients with a diagnosis of&#xD;
             diabetes, but without venous stasis disease).&#xD;
&#xD;
          -  Wound present for &gt;30 days.&#xD;
&#xD;
          -  Patient has wound in location amenable to creation of airtight seal around wound using&#xD;
             TNP dressings.&#xD;
&#xD;
          -  Patient is able to comply with study protocol requirements.&#xD;
&#xD;
          -  Patient is able to understand and provide written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient has evidence of wound infection in the opinion of the physician.&#xD;
&#xD;
          -  Patient has a thick eschar that persists after wound debridement.&#xD;
&#xD;
          -  Patient has an HbA1C &gt;12%.&#xD;
&#xD;
          -  Patient has ulcers due to inflammatory conditions such as pyoderma gangrenosum,&#xD;
             rheumatoid arthritis, vasculitis, cryoglobulinaemia, necrobiosis lipoidica,&#xD;
             panniculitis, lupus erythematosus, scleroderma, or calcinosis.&#xD;
&#xD;
          -  Patient has untreated osteomyelitis.&#xD;
&#xD;
          -  Patient has any other condition that, in the opinion of the investigator, makes the&#xD;
             patient inappropriate to take part in this study.&#xD;
&#xD;
          -  Patient is allergic to the wound care device or occlusive dressing.&#xD;
&#xD;
          -  Patient has exposed blood vessels.&#xD;
&#xD;
          -  Patient is pregnant or pregnancy is suspected.&#xD;
&#xD;
          -  Patient is actively participating in other clinical trials that may interfere with&#xD;
             their participation in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Section of Wound Healing</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF14 4XN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 12, 2011</study_first_submitted>
  <study_first_submitted_qc>August 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2011</study_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

